Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Juan-Juan Qin and Qingbo Xu.
Juan-Juan Qin
Connection Strength
0.560
Qingbo Xu
  1. Redefining Cardiac Biomarkers in Predicting Mortality of Inpatients With COVID-19. Hypertension. 2020 10; 76(4):1104-1112.
    View in: PubMed
    Score: 0.223
  2. Development and validation of a risk score using complete blood count to predict in-hospital mortality in COVID-19 patients. Med (N Y). 2021 Apr 09; 2(4):435-447.e4.
    View in: PubMed
    Score: 0.058
  3. The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19. Cell Metab. 2021 02 02; 33(2):258-269.e3.
    View in: PubMed
    Score: 0.058
  4. Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes. Cell Metab. 2020 10 06; 32(4):537-547.e3.
    View in: PubMed
    Score: 0.056
  5. In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19. Cell Metab. 2020 08 04; 32(2):176-187.e4.
    View in: PubMed
    Score: 0.056
  6. Comparative Impacts of ACE (Angiotensin-Converting Enzyme) Inhibitors Versus Angiotensin II Receptor Blockers on the Risk of COVID-19 Mortality. Hypertension. 2020 08; 76(2):e15-e17.
    View in: PubMed
    Score: 0.055
  7. Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19. Circ Res. 2020 06 05; 126(12):1671-1681.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.